• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Syncom Formulations (India) Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3544.0
  • ISIN : INE312C01025
20.40 1 (2.77%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    19.87

  • Today’s High

    21.00

  • Open

    19.87

  • Perv Close

    19.85

  • 52W Low

    10.21

  • 52W High

    22.59

Key Indicators

  • P/E(TTM)

    22.67

  • Mar.Cap (₹Cr.)

    1,917.60

  • Div & Yield %

    0.49

  • Book Value(₹)

    4.39

  • Debt-Equity Ratio

    2.77

  • AGM Date

    22-Sep-2026

  • EPS

    0.90

  • P/E Ratio

    22.67

Financials Ratios

  • Debt-Equity Ratio

    0.29

  • Mar.Cap (₹Cr.)

    1,917.60

  • RONW (%)

    9.30

  • ROCE (%)

    10.91

Score Board

  • Equity (₹ in Cr.)

    94.00

  • BV (₹)

    4.40

  • Sales( ₹ in Cr.)

    486.57

  • NP (in Cr.)

    66.20

  • NP Var(%)

    37.0

  • Div%

    10.0

  • CPS (₹)

    0.80

  • EPS (₹)

    0.70

  • Traded Value (₹ in Lakhs)

    1,917.60

  • 52 Week High

    22.59

  • 52 Week Low

    10.21

  • Price BSE

    20.0

  • Price NSE

    20.00

  • Market Capital( in Cr.)

    1,917.60

  • P/C Ratio

    25.80

  • P/E Ratio

    28.40

  • Price Vs.BV

    0.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 486.57 462.85 258.36 224.64 219.66 244.81
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 486.57 462.85 258.36 224.64 219.66 244.81
Other Income 31.00 17.20 13.10 14.62 12.02 7.17
Stock Adjustments 3.90 10.62 2.18 -0.05 -3.32 4.05
Total Income 521.47 490.67 273.64 239.21 228.36 256.03
EXPENDITURE :            
Raw Materials 287.64 317.51 157.74 142.07 137.23 165.51
Power and Fuel Cost 6.19 5.62 6.13 5.31 4.38 3.84
Employee Cost 65.08 50.56 33.57 24.44 20.73 18.24
Other Manufacturing Expenses 4.16 2.88 2.39 3.19 2.26 2.09
Selling and Administration Expenses 44.57 39.22 29.62 27.29 29.71 19.79
Miscellaneous Expenses 5.67 4.00 3.03 2.41 2.00 1.34
Employee Benefit Expenses 65.08 50.56 33.57 24.44 20.73 18.24
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 413.31 419.79 232.47 204.71 196.32 210.81
Operating Profit 108.17 70.88 41.18 34.51 32.05 45.22
Interest 1.11 1.03 4.70 3.40 1.93 0.48
Gross Profit 107.06 69.85 36.48 31.11 30.12 44.74
Depreciation 6.53 5.19 4.72 4.54 3.95 4.03
Profit Before Tax 100.53 64.66 31.76 26.57 26.17 40.71
Current Tax 22.70 14.45 7.58 6.65 6.25 11.30
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.81 1.33 0.55 -0.15 0.14 0.23
Reported Net Profit 76.01 48.87 23.62 20.07 19.79 29.17
Extraordinary Items 9.80 0.52 0.55 0.14 0.03 0.10
Adjusted Net Profit 66.21 48.35 23.07 19.93 19.76 29.07
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 151.86 102.99 79.36 62.11 42.32 13.15
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 2.82 0.00 0.00
P & L Balance carried down 227.87 151.86 102.99 79.36 62.11 42.32
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 0.00 0.00 0.00 3.00 0.00
Dividend Per Share(Rs) 0.10 0.00 0.00 0.00 0.03 0.00
Earnings Per Share-Unit Curr 0.81 0.52 0.25 0.21 0.23 0.37
Earnings Per Share(Adj)-Unit Curr 0.81 0.52 0.25 0.21 0.23 0.37
Book Value 4.39 3.62 3.05 2.72 2.52 2.25
Book Value(Adj)-Unit Curr 4.39 3.62 3.05 2.72 2.52 2.25

Shareholding Pattern

  • Promoter Group

    50.57%

  • Public Share Holding

    49.43%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 83,061,125 8.84 83,061,125 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 392,286,474 41.73 392,286,474 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 475,347,599 50.57 475,347,599 13
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 7,000 0.00 7,000 1
Clearing Members 0 0.00 0 0
Corporate Bodies 4,500 0.00 4,500 1
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 3,280,678 0.35 3,280,678 15
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 18,925 0.00 18,925 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 3,311,103 0.35 3,311,103 19
2] Non Institution
Bodies Corporate 9,486,453 1.01 9,483,953 199
Clearing Members 317,562 0.03 317,562 22
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 17,047,220 1.81 16,944,720 2,035
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 9,959,452 1.06 9,959,452 1,744
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 61,145,776 6.50 61,145,776 141
Individuals holding nominal share capital up to Rs. 1 lakh 360,906,020 38.39 358,589,340 417,919
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 2,320,331 0.25 2,320,331 1
Sub Total 461,341,298 49.08 458,919,618 422,082
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 940,000,000 100.00 937,578,320 422,114

Company Background

Syncom Formulations (India) LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Syncom Formulations (India) Ltd
  • BSE Code : 3544.0
  • ISIN : INE312C01025

  • Incorporation Year

    1988

  • Registered Office

    7 Niraj Indl Estate Andheri(E)
    Off Mahakali Caves Rd, Mumbai,
    Maharashtra-400093

  • Telephone

    91-22-30887744

  • FAX

    91-22-30887755

  • Chairman

    ANKIT KEDARMAL BANKDA

  • Managing Director

    Rahul Vijay Bankda

  • Company Secretary

    Vaishali Agrawal

  • Auditor

    Sanjay Mehta & Associates

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Syncom Formulations (India) Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Syncom Formul. 20.40 517.54 486.57 22.67 26.42
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77